Product News

Share this article:

Forest Laboratories and Cypress Bioscience launched Savella, a selective serotonin and norepinephrine dual reuptake inhibitor, for fibromyalgia. The product will be available in drug stores April 28.

 

Sanofi-Aventis launched Apidra SoloSTAR, an insulin pen, indicated for adults and children 4 years and older, with type 1 diabetes or adults with type 2 diabetes.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.